CompletedPhase 2ACTRN12617001540303
Steroids To Reduce the Impact on DElirium study (STRIDE)
Steroids To Reduce the Impact on DElirium (STRIDE) study - pilot randomised controlled trial of preoperative dexamethasone to prevent delirium after hip fracture.
Sponsor
Waitemata District Health Board
Enrollment
80 participants
Start Date
Nov 14, 2018
Study Type
Interventional
Conditions
Summary
This randomised, placebo-controlled, double-blind clinical trial will include 80 patients aged 65 and over admitted for hip fracture.
Eligibility
Sex: Both males and femalesMin Age: 65 Yearss
Inclusion Criteria2
- years and older
- Fractured neck of femur
Exclusion Criteria6
- Dementia or any cognitive deficit
- Delirium on admission
- Used steroids in the last 7 days
- Significant and poorly controlled diabetes (glucose >12 mmol/l on admission)
- Systemic infection
- Unable to read and speak English
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Dexamethasone (20mg) intravenous infusion delivered once (as early as possible after acute admission to hospital)
Dexamethasone (20mg) intravenous infusion delivered once (as early as possible after acute admission to hospital)
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12617001540303
Related Trials
Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery
NCT069692871 location
Computer-assisted Cognitive Stimulation Treatment for Delirium
NCT075632441 location
TaVNS for Delirium
NCT072580821 location
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
NCT053730176 locations
Automating Delirium Severity in the ICU
NCT061724911 location